emergent logo.jpg
Emergent BioSolutions Reports Financial Results For Second Quarter 2021
July 29, 2021 16:05 ET | Emergent BioSolutions
Reaffirms 2021 Full Year Forecast for Revenues and Profit GAITHERSBURG, Md., July 29, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the second...
emergent logo.jpg
Emergent BioSolutions Reports Financial Results for First Quarter 2021
April 29, 2021 16:05 ET | Emergent BioSolutions
Revises 2021 Financial Forecast GAITHERSBURG, Md., April 29, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the quarter ended March 31, 2021. ...
emergent logo.jpg
Emergent BioSolutions Reports Financial Results for Fourth Quarter and Full Year 2020
February 18, 2021 16:05 ET | Emergent BioSolutions
Reports record fourth quarter and year to date 2020 performance, in line with prior guidanceReaffirms full year 2021 forecast GAITHERSBURG, Md., Feb. 18, 2021 (GLOBE NEWSWIRE) --...
emergent logo.jpg
Emergent BioSolutions Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2020 and Updates Full Year 2020 Guidance
November 05, 2020 16:05 ET | Emergent BioSolutions
Reports strong third quarter and record year to date performanceUpdates full year guidance — refines revenue ranges and raises profitability ranges GAITHERSBURG, Md., Nov. 05, 2020 (GLOBE NEWSWIRE)...
emergent logo.jpg
Emergent BioSolutions to Release Second Quarter 2020 Financial Results and Conduct Conference Call on July 30, 2020
July 16, 2020 06:30 ET | Emergent BioSolutions
GAITHERSBURG, Md., July 16, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, July 30, 2020 at 5:00 pm (Eastern Time) to discuss the financial...
emergent logo.jpg
Emergent BioSolutions Reports Financial Results for First Quarter 2020
April 30, 2020 16:08 ET | Emergent BioSolutions
Reaffirms full year 2020 financial forecastExecutes multi-faceted response to COVID-19 drawing upon longstanding investments in capabilities to address public health threats, as well as expertise in...
emergent logo.jpg
Emergent BioSolutions Reports Financial Results for Fourth Quarter and Full Year 2019
February 20, 2020 16:31 ET | Emergent BioSolutions
GAITHERSBURG, Md., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) reported financial results for the quarter and year ended December 31, 2019. FINANCIAL HIGHLIGHTS (in...
emergent logo.jpg
Emergent BioSolutions Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2019
November 06, 2019 16:05 ET | Emergent BioSolutions
Q3 2019 performance above guidance Full year 2019 financial forecast reaffirmed GAITHERSBURG, Md., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) reported financial...
emergent logo.jpg
Emergent BioSolutions Reports Financial Results for Second Quarter and Six Months Ended June 30, 2019
August 01, 2019 16:05 ET | Emergent BioSolutions
Reaffirms full year 2019 financial forecast and operational goalsProvides Q3 2019 revenue forecast of $245M-$275M GAITHERSBURG, Md., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc....
emergent logo.jpg
Emergent BioSolutions to Release Second Quarter 2019 Financial Results and Conduct a Conference Call on August 1, 2019
July 18, 2019 06:30 ET | Emergent BioSolutions
GAITHERSBURG, Md., July 18, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, August 1, 2019 at 5:00 pm (Eastern Time) to discuss the financial...